LRDG — 27 Health Holdings Income Statement
0.000.00%
Last trade - 00:00
Consumer CyclicalsHighly SpeculativeMicro Cap
- $0.00m
- $1.91m
- $0.00m
2015 July 31st | 2016 July 31st | 2017 July 31st | 2018 July 31st | 2019 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.001 | 0.002 | 0.084 | 0.003 | 0.001 |
Cost of Revenue | |||||
Gross Profit | 0.001 | 0.002 | — | — | -0.011 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.027 | 0.328 | 2.65 | 5.84 | 0.345 |
Operating Profit | -0.026 | -0.326 | -2.57 | -5.84 | -0.344 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.045 | -0.345 | -2.77 | -6.43 | -0.491 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.045 | -0.345 | -2.77 | -6.43 | -0.491 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.045 | -0.345 | -2.77 | -6.43 | -0.491 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.045 | -0.345 | -2.77 | -6.43 | -0.491 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -21.8 | -166 | -1,283 | -930 | -15.3 |
Dividends per Share |